Cleveland Clinic’s Nissen Asks HELP Panel For Stronger Supplement Regulation
This article was originally published in The Tan Sheet
Executive Summary
Pending legislation on adverse event reporting does not go far enough in expanding regulatory oversight of dietary supplements, the American College of Cardiology president told a Senate committee Nov. 16
You may also be interested in...
With Democrat In White House, “More Aggressive” FDA Comes Into Focus
Democratic control of the White House, Senate and House brings the potential of a "more aggressive" FDA into sharp focus
With Democrat In White House, “More Aggressive” FDA Comes Into Focus
Democratic control of the White House, Senate and House brings the potential of a "more aggressive" FDA into sharp focus
With Democrat In White House, “More Aggressive” FDA Comes Into Focus
Democratic control of the White House, Senate and House brings the potential of a "more aggressive" FDA into sharp focus